391 related articles for article (PubMed ID: 21289056)
1. Role of smooth muscle protein SM22α in glomerular epithelial cell injury.
Marshall CB; Krofft RD; Blonski MJ; Kowalewska J; Logar CM; Pippin JW; Kim F; Feil R; Alpers CE; Shankland SJ
Am J Physiol Renal Physiol; 2011 Apr; 300(4):F1026-42. PubMed ID: 21289056
[TBL] [Abstract][Full Text] [Related]
2. The glomerular parietal epithelial cell's responses are influenced by SM22 alpha levels.
Naito S; Pippin JW; Shankland SJ
BMC Nephrol; 2014 Nov; 15():174. PubMed ID: 25376243
[TBL] [Abstract][Full Text] [Related]
3. Fn14 in podocytes and proteinuric kidney disease.
Sanchez-Niño MD; Poveda J; Sanz AB; Mezzano S; Carrasco S; Fernandez-Fernandez B; Burkly LC; Nair V; Kretzler M; Hodgin JB; Ruiz-Ortega M; Selgas R; Egido J; Ortiz A
Biochim Biophys Acta; 2013 Dec; 1832(12):2232-43. PubMed ID: 23999007
[TBL] [Abstract][Full Text] [Related]
4. Quantitative histological analysis of SM22α (transgelin) in an adriamycin-induced focal segmental glomerulosclerosis model.
Wang X; Sakatsume M; Sakamaki Y; Inomata S; Yamamoto T; Narita I
Nephron Exp Nephrol; 2012; 120(1):e1-11. PubMed ID: 22205114
[TBL] [Abstract][Full Text] [Related]
5. SM22alpha: the novel phenotype marker of injured glomerular epithelial cells in anti-glomerular basement membrane nephritis.
Ogawa A; Sakatsume M; Wang X; Sakamaki Y; Tsubata Y; Alchi B; Kuroda T; Kawachi H; Narita I; Shimizu F; Gejyo F
Nephron Exp Nephrol; 2007; 106(3):e77-87. PubMed ID: 17519556
[TBL] [Abstract][Full Text] [Related]
6. Injured kidney cells express SM22α (transgelin): Unique features distinct from α-smooth muscle actin (αSMA).
Sakamaki Y; Sakatsume M; Wang X; Inomata S; Yamamoto T; Gejyo F; Narita I
Nephrology (Carlton); 2011 Feb; 16(2):211-8. PubMed ID: 21272134
[TBL] [Abstract][Full Text] [Related]
7. Plasminogenuria is associated with podocyte injury, edema, and kidney dysfunction in incident glomerular disease.
Egerman MA; Wong JS; Runxia T; Mosoyan G; Chauhan K; Reyes-Bahamonde J; Anandakrishnan N; Wong NJ; Bagiella E; Salem F; Meliambro K; Li H; Azeloglu EU; Coca SG; Campbell KN; Raij L
FASEB J; 2020 Dec; 34(12):16191-16204. PubMed ID: 33070369
[TBL] [Abstract][Full Text] [Related]
8. Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.
Eriguchi M; Yotsueda R; Torisu K; Kawai Y; Hasegawa S; Tanaka S; Noguchi H; Masutani K; Kitazono T; Tsuruya K
Am J Physiol Renal Physiol; 2016 Feb; 310(4):F322-33. PubMed ID: 26632605
[TBL] [Abstract][Full Text] [Related]
9. Podocyte-Specific Induction of Krüppel-Like Factor 15 Restores Differentiation Markers and Attenuates Kidney Injury in Proteinuric Kidney Disease.
Guo Y; Pace J; Li Z; Ma'ayan A; Wang Z; Revelo MP; Chen E; Gu X; Attalah A; Yang Y; Estrada C; Yang VW; He JC; Mallipattu SK
J Am Soc Nephrol; 2018 Oct; 29(10):2529-2545. PubMed ID: 30143559
[TBL] [Abstract][Full Text] [Related]
10. Loss of Roundabout Guidance Receptor 2 (Robo2) in Podocytes Protects Adult Mice from Glomerular Injury by Maintaining Podocyte Foot Process Structure.
Pisarek-Horowitz A; Fan X; Kumar S; Rasouly HM; Sharma R; Chen H; Coser K; Bluette CT; Hirenallur-Shanthappa D; Anderson SR; Yang H; Beck LH; Bonegio RG; Henderson JM; Berasi SP; Salant DJ; Lu W
Am J Pathol; 2020 Apr; 190(4):799-816. PubMed ID: 32220420
[TBL] [Abstract][Full Text] [Related]
11. Expression of CCN1 (CYR61) in developing, normal, and diseased human kidney.
Sawai K; Mukoyama M; Mori K; Kasahara M; Koshikawa M; Yokoi H; Yoshioka T; Ogawa Y; Sugawara A; Nishiyama H; Yamada S; Kuwahara T; Saleem MA; Shiota K; Ogawa O; Miyazato M; Kangawa K; Nakao K
Am J Physiol Renal Physiol; 2007 Oct; 293(4):F1363-72. PubMed ID: 17699553
[TBL] [Abstract][Full Text] [Related]
12. Induction of podocyte-derived VEGF ameliorates podocyte injury and subsequent abnormal glomerular development caused by puromycin aminonucleoside.
Ma J; Matsusaka T; Yang HC; Zhong J; Takagi N; Fogo AB; Kon V; Ichikawa I
Pediatr Res; 2011 Jul; 70(1):83-9. PubMed ID: 21451433
[TBL] [Abstract][Full Text] [Related]
13. De novo expression of podocyte proteins in parietal epithelial cells during experimental glomerular disease.
Ohse T; Vaughan MR; Kopp JB; Krofft RD; Marshall CB; Chang AM; Hudkins KL; Alpers CE; Pippin JW; Shankland SJ
Am J Physiol Renal Physiol; 2010 Mar; 298(3):F702-11. PubMed ID: 20007346
[TBL] [Abstract][Full Text] [Related]
14. Podocyte expression of the CDK-inhibitor p57 during development and disease.
Hiromura K; Haseley LA; Zhang P; Monkawa T; Durvasula R; Petermann AT; Alpers CE; Mundel P; Shankland SJ
Kidney Int; 2001 Dec; 60(6):2235-46. PubMed ID: 11737597
[TBL] [Abstract][Full Text] [Related]
15. Rituximab protects podocytes and exerts anti-proteinuric effects in rat adriamycin-induced nephropathy independent of B-lymphocytes.
Takahashi Y; Ikezumi Y; Saitoh A
Nephrology (Carlton); 2017 Jan; 22(1):49-57. PubMed ID: 26833819
[TBL] [Abstract][Full Text] [Related]
16. Differential expression of d-type cyclins in podocytes in vitro and in vivo.
Petermann A; Hiromura K; Pippin J; Blonski M; Couser WG; Kopp J; Mundel P; Shankland SJ
Am J Pathol; 2004 Apr; 164(4):1417-24. PubMed ID: 15039229
[TBL] [Abstract][Full Text] [Related]
17. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy.
Barisoni L; Kriz W; Mundel P; D'Agati V
J Am Soc Nephrol; 1999 Jan; 10(1):51-61. PubMed ID: 9890309
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D down-regulates TRPC6 expression in podocyte injury and proteinuric glomerular disease.
Sonneveld R; Ferrè S; Hoenderop JG; Dijkman HB; Berden JH; Bindels RJ; Wetzels JF; van der Vlag J; Nijenhuis T
Am J Pathol; 2013 Apr; 182(4):1196-204. PubMed ID: 23385000
[TBL] [Abstract][Full Text] [Related]
19. Distinct Functional Requirements for Podocalyxin in Immature and Mature Podocytes Reveal Mechanisms of Human Kidney Disease.
Refaeli I; Hughes MR; Wong AK; Bissonnette MLZ; Roskelley CD; Wayne Vogl A; Barbour SJ; Freedman BS; McNagny KM
Sci Rep; 2020 Jun; 10(1):9419. PubMed ID: 32523052
[TBL] [Abstract][Full Text] [Related]
20. Basic fibroblast growth factor augments podocyte injury and induces glomerulosclerosis in rats with experimental membranous nephropathy.
Floege J; Kriz W; Schulze M; Susani M; Kerjaschki D; Mooney A; Couser WG; Koch KM
J Clin Invest; 1995 Dec; 96(6):2809-19. PubMed ID: 8675651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
